Core Points - Holzer & Holzer, LLC is investigating whether Telix Pharmaceuticals Limited complied with federal securities laws following a subpoena from the U.S. Securities and Exchange Commission regarding the company's disclosures on prostate cancer therapeutic candidates [1] - The announcement of the subpoena led to a decline in Telix's stock price [1] Company Information - Telix Pharmaceuticals Limited is publicly traded on NASDAQ under the ticker TLX [1] - The company is involved in the development of therapeutic candidates for prostate cancer [1] Legal Context - Holzer & Holzer, LLC is a law firm specializing in securities litigation, representing shareholders and investors in various legal actions [3] - The firm has a history of recovering significant amounts for shareholders affected by corporate misconduct [3]
INVESTOR ALERT: Investigation of Telix Pharmaceuticals Limited (TLX) Announced by Holzer & Holzer, LLC